COMMUNIQUÉS West-GlobeNewswire

Genfit: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial
08/07/2025
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), July 8, 2025 - GENFIT (Nasdaq and Euronext: GNFT) , a biopharmaceutical company dedicated to improving the lives of patients with rare and [...]
Genfit : Bilan semestriel du contrat de liquidité contracté avec le Crédit Industriel et Commercial
08/07/2025
Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 8 juillet 2025 – GENFIT (Nasdaq et Euronext: GNFT) , société biopharmaceutique engagée dans l’amélioration de la vie des patients atteints de [...]
BrightSpring Health Services, Inc. to Announce Second Quarter 2025 Financial Results on August 1, 2025
08/07/2025
LOUISVILLE, Ky., July 08, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that it plans to release its second quarter 2025 financial results [...]
Enovis to Host Second Quarter 2025 Results Conference Call on August 7th
08/07/2025
Wilmington, DE, July 08, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to [...]
Solid Biosciences Announces FDA IND and Health Canada CTA Approval for First-in-Class Cardiac Gene Therapy to Treat Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
08/07/2025
- SGT-501 is a novel gene therapy for rare, life-threatening, genetic arrhythmogenic disease with no approved therapies - - SGT-501 has received Orphan Drug Designation and Rare Pediatric Disease Designation from the [...]
RxSight, Inc. Announces Preliminary Second Quarter 2025 Revenue and Revised 2025 Guidance
08/07/2025
ALISO VIEJO, Calif., July 08, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, [...]
Lixte Biotechnology Holdings, Inc. Announces the Closing of $1.5 Million Registered Direct Offering
08/07/2025
PASADENA, CALIF, July 08, 2025 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) (the “Company”), a clinical stage pharmaceutical company, today announced the closing of a registered direct offering [...]
LeMaitre Will Announce Second Quarter 2025 Earnings Results August 5, 2025
08/07/2025
BURLINGTON, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2025 financial results on Tuesday, August 5, 2025, after the market [...]
Rhythm Pharmaceuticals To Announce Topline Results from Phase 2 Trial Evaluating Oral MC4R Agonist Bivamelagon in Acquired Hypothalamic Obesity
08/07/2025
BOSTON, July 08, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine [...]
New Fat Burner for Women Launched Over the Counter - PhenQ Medically Accredited Fat Burning Supplement
08/07/2025
Clinicians’ Choice Fat Burner for Women, PhenQ: Clinically Endorsed by 800 Healthcare Professionals Launched Over the Counter in the USA and Worldwide. New York City, NY, July 08, 2025 (GLOBE NEWSWIRE) -- Women [...]
Transforming Healthcare Ltd Launches the Healthcare Convergence Framework: A Pioneering AI/Robotics Readiness Assessment Tool for Healthcare
08/07/2025
Transforming Healthcare Ltd Unveils the Healthcare Convergence Framework® AI/Robotics Self-Assessment Scorecard London, UK , July 08, 2025 (GLOBE NEWSWIRE) -- Transforming Healthcare Ltd, a leader in healthcare [...]
ZyVersa Therapeutics Announces a Warrant Inducement Transaction for $2.0 Million in Gross Proceeds
08/07/2025
WESTON, Fla., July 08, 2025 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA; “ZyVersa”), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of patients with [...]
From Stem Cells to CAR-T: LivMedCell Expands Its Role in the Future of Medicine
08/07/2025
Photo: LivMedCell via FL Communications ISTANBUL, July 08, 2025 (GLOBE NEWSWIRE) -- LivMedCell has officially launched a groundbreaking research collaboration with the University of Pennsylvania’s Perelman School of [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 27- 2025
08/07/2025
Aggregated presentation by day and by market Statement of transactions in own shares from June 30th to July 4th 2025 Name of the issuer Identity code of the issuer (Legal Entity Identifier) Day of the transaction [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 27 - 2025
08/07/2025
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 30 juin au 04 juillet 2025 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction [...]
Report on Carbios’ liquidity contract with Natixis ODDO BHF
08/07/2025
PRESS RELEASE REGULATED INFORMATION: ONGOING Shares concerned: Carbios (ISIN code: FR0011648716) Market concerned: Euronext Growth Paris Clermont-Ferrand (France), 08 July 2025 (18:00 CEST). CARBIOS , (Euronext Growth [...]
CARBIOS : Bilan semestriel du contrat de liquidité confié à Natixis ODDO BHF
08/07/2025
COMMUNIQUÉ DE PRESSE INFORMATION REGLEMENTEE : PERMANENTE Titre concerné : Carbios (code ISIN FR0011648716) Marché concerné : Euronext Growth Paris Clermont-Ferrand (France), le 08 juillet 2025 (18h00 CEST). CARBIOS, ( [...]
BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE S1 2025
08/07/2025
Communiqué de presse BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE S1 2025 Dijon, France 08 juillet 2025 (17h30 CET) -- CROSSJECT (ISIN: FR0011716265; Euronext: ALCJ), la société pharmaceutique de spécialités qui développe [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30 juin 2025
08/07/2025
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30 juin 2025 En application de l'article L. 233-8 II du code de commerce et de l'article 222-12-5 du règlement général de l'AMF, les [...]

Pages